Callan JMB Inc

CJMB

Market cap $4.05M

Approval enhances the Company's ability to receive, prepare, and deploy pediatric-focused medical materials in support of state and local public health initiatives

Strategic extension reinforces recurring revenue visibility and growing demand for preparedness, continuity, and cold chain infrastructure Spring Branch, TX, May 20, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced the expansion and extension of an existing long-term public sector infrastructure engagement valued at approximately $175,000 per month over the next six months. The agreement represents approximately $1.05 million in projected recurring revenue over the next six months, tied to continued operational support, specialized storage, preparedness operations, monitoring, and mission-critical logistics services under an active governmental infrastructure initiative.

Spring Branch, TX, April 17, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today issued a statement in response to a recently filed lawsuit in the U.S. District Court for the Northern District of Texas.

Reverse Distribution Coordination Delivered Necessary Medical Supplies to Requesting Jurisdictions through its Established Emergency Preparedness Network

Independent oversight reinforces manufacturing, supply chain integrity, and federal readiness for a platform designed to scale across multiple indications

Callan JMB Inc. (CJMB) Presents at IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 Transcript

GALVESTON, TX / ACCESS Newswire / January 12, 2026 / Callan JMB Inc. (NASDAQ:CJMB), a premier provider of vertically integrated temperature-controlled logistics and specialized life sciences fulfillment, today announced a comprehensive strategic realignment to address the critical infrastructure gap in the global distribution of GLP-1 (glucagon-like peptide-1) medications. As the pharmaceutical industry faces a logistics bottleneck due to the meteoric rise of weight-management and diabetes treatments such as Ozempic®, Wegovy®, and Mounjaro®, Callan JMB is positioning its proprietary cold-chain technology to become the primary "last-mile" fulfillment partner for large-scale telehealth and pharmaceutical distributors.

Move leverages the Company's expertise in regulated materials to capture opportunities in sustainable , high-growth consumer markets

Sentry Monitoring System allows for remote monitoring of refrigerators, freezers, and clean room temperatures for high-value pharmaceutical products in pharmacies, hospitals, and emergency preparedness facilities

SPRING BRANCH, Texas, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that management will participate in the following September 2025 investment conferences.